Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what consultation with GPs he undertook when developing his position on the Off-patent Drugs Bill.
In developing our response, we have taken advice from clinicians and officials at NHS England, the National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency, and taken account of views expressed by other stakeholder organisations.